Concourse Financial Group Securities, Inc. Mannkind Corp Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 74 shares of MNKD stock, worth $509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74
Previous 74 -0.0%
Holding current value
$509
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
BUY
$2.62 - $4.45 $193 - $329
74 New
74 $0
Q4 2021

Feb 07, 2022
BUY
$4.05 - $5.37 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$3.89 - $5.48 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$3.61 - $5.45 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$3.14 - $6.14 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$1.79 - $4.04 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$1.56 - $2.08 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$0.94 - $2.21 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$0.84 - $1.76 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.14 - $1.49 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$1.04 - $1.44 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$1.09 - $1.88 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$1.14 - $2.25 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$1.02 - $2.05 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$1.01 - $2.19 $0 - $0
0 New
0 $0

Others Institutions Holding MNKD

# of Institutions
245
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.77B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email